Knee injections Gastonia NC patients are researching can include corticosteroid injections, hyaluronic acid injections for selected knee osteoarthritis patients and platelet-rich plasma therapy when clinically appropriate. Joint Health Solutions serves adults from Gastonia and nearby Gaston County communities at its clinic located at 9350 Benfield Rd, #109, Charlotte, NC 28269.
An injection is not automatically appropriate for every painful knee. The first step is an evaluation of the symptoms, health history, medications, knee function, previous care and treatment goals. The purpose is to determine whether injection-based care, conservative treatment, additional evaluation or orthopedic referral represents the most reasonable next step.
Knee injections can be considered for selected patients with knee osteoarthritis, painful inflammatory flare-ups, stiffness, swelling or activity-limiting symptoms. Options can include short-term cortisone support, hyaluronic acid for selected knee osteoarthritis patients and PRP therapy with important evidence limitations. Toradol IM can also provide short-term acute-pain support for appropriate patients, but it is injected into a muscle rather than into the knee joint. No injection rebuilds cartilage or guarantees permanent relief, and treatment selection requires an individualized clinical evaluation.
Knee injections provide a nonsurgical treatment pathway for selected patients whose symptoms have not responded adequately to activity changes, exercise-based care, medication discussions or other conservative approaches. Their role depends on the diagnosis and the type of injection being considered.
An intra-articular injection places medication or another prepared substance into the knee joint. Other injections can be directed around a bursa or another carefully selected knee structure when the diagnosis supports that approach.
Corticosteroid injections can provide short-term symptom support for some patients with symptomatic knee osteoarthritis. They do not heal cartilage or correct the structural cause of arthritis.
Reducing pain or inflammation can make walking, stairs, strengthening exercises and daily movement more manageable for some patients. Improvement in symptoms does not demonstrate cartilage restoration or structural healing.
An injection is often one component of care rather than a complete treatment plan. Depending on the findings, the broader plan can include activity modification, low-impact exercise, physical therapy, weight and nutrition support, knee bracing, aspiration of excess knee fluid or orthopedic referral.
Treatment recommendations depend on the cause of the knee symptoms, medical history, current medications, previous treatment, and clinical findings.
Corticosteroid injections, commonly called cortisone injections, are used for short-term support when knee inflammation contributes to pain, stiffness, or reduced movement.
Hyaluronic acid injections, also called viscosupplementation, can be discussed for selected patients with symptomatic knee osteoarthritis.
Platelet-rich plasma, or PRP, is prepared from a sample of the patient’s blood and injected into the selected knee treatment area.
Toradol IM is ketorolac administered into a muscle rather than the knee joint. It may be considered only for short-term acute-pain support after individual risk review.
Knee injections can be discussed when symptoms and clinical findings support a specific treatment target.
Common considerations include:
An injection does not treat every possible cause of knee pain. Ligament tears, fractures, infection, gout, a physically locked knee and some meniscus injuries require different evaluation or treatment pathways.
Patients with undiagnosed knee symptoms can first review knee pain treatment near Gastonia. Patients researching injections for both knees and shoulders can review joint injections near Gastonia.
Seek prompt or urgent medical assessment for:
These symptoms should not be delayed while waiting for a routine injection consultation.
Image guidance can be used when clinically appropriate to help a provider visualize the treatment target and guide needle placement. The technique selected can depend on the procedure, anatomy, previous surgery, amount of swelling and clinical objective.
Image guidance does not make every patient an appropriate injection candidate, and it does not guarantee a particular result. Some knee injections can be completed using anatomical landmarks, while other procedures can benefit from ultrasound or fluoroscopic guidance. The provider should explain which method is planned and why.
If existing X-rays, MRI reports or other records are available, they can be reviewed during treatment planning. Additional imaging, laboratory evaluation, urgent assessment or specialist referral can be recommended when clinically appropriate. Joint Health Solutions should not be described as automatically performing diagnostic imaging or laboratory testing.
Every injection has potential risks. The specific risk profile depends on the substance used, injection target, health history, medications and frequency of treatment.
Possible local risks can include:
Cortisone can temporarily affect blood glucose and can create additional concerns with repeated exposure. Hyaluronic acid can cause a temporary inflammatory reaction. PRP can cause soreness after treatment and does not work consistently for every patient. Because the needle passes through the skin, careful sterile technique is important for reducing infection risk.
Ketorolac has systemic risks that differ from those of a joint injection. Important concerns include gastrointestinal ulceration or bleeding, impaired kidney function, cardiovascular events and effects on bleeding. It is not appropriate for every patient and is restricted to short-term use.
No fixed result period applies to every patient. Response depends on the diagnosis, arthritis severity, injection type, health history, activity demands, previous response and other parts of the care plan.
| Treatment | Expected Response Pattern | Evidence Considerations | Important Limitations |
|---|---|---|---|
| Cortisone | Symptom improvement can begin after treatment, but onset and duration differ. | AAOS supports a potential short-term role for symptomatic knee osteoarthritis. | Does not heal cartilage or provide permanent arthritis correction. |
| Hyaluronic Acid | Improvement, when it occurs, can develop gradually. | Professional recommendations differ; AAOS advises against routine use. | Limited to selected knee osteoarthritis patients and does not rebuild cartilage. |
| PRP | Improvement can be gradual and response varies. | AAOS classifies knee osteoarthritis evidence as limited. | No universal preparation, schedule, duration, or guaranteed structural benefit. |
| Toradol IM | Intended only for short-term acute-pain support. | Ketorolac is a systemic NSAID medication. | Not a knee-joint injection and not chronic arthritis or stiffness treatment. |
No response pattern guarantees that another injection should be repeated. Follow-up decisions should be based on benefit, side effects, health history, alternatives and the overall treatment plan.
Knee-Focused Evaluation
The evaluation considers symptoms, function, swelling, stability, previous treatment and activity goals before an injection is recommended.
Individualized Treatment Selection
Cortisone, hyaluronic acid and PRP have different purposes, evidence profiles, risks and limitations. The treatment plan should match the diagnosis rather than applying one injection to every patient.
Conservative Care Integration
Injection-based care can be coordinated with movement support, activity modification, physical therapy, bracing, weight and nutrition support or knee arthrocentesis when excess knee fluid is present and aspiration is clinically appropriate.
Clear Referral Guidance
An orthopedic referral can be recommended when symptoms, instability, major structural damage or limited response to nonsurgical care indicate that a surgical opinion is appropriate.
Verified Care Team
Ariel Curtis, FNP-C, is listed by Joint Health Solutions as a Joint Injection Specialist. Jeffrey Galvin, MD, is listed as Medical Director. Provider credentials should be presented accurately without adding a medical-review statement unless documented review has occurred.
Serving Gastonia-Area Patients
Joint Health Solutions welcomes patients from Gastonia, Belmont, Cramerton, Dallas, Mount Holly, Bessemer City and other Gaston County communities. Appointments are held at the Charlotte clinic rather than a Gastonia office.
Most knee injections involve a brief pinch, pressure or temporary discomfort. The experience differs according to the injection target, medication, amount of swelling and individual sensitivity. Mild soreness can occur afterward. The provider should explain what is expected, how the skin will be prepared and which symptoms would require a call to the clinic.
The response depends on the treatment. Cortisone is used for short-term symptom support, while hyaluronic acid and PRP can have a more gradual response when improvement occurs. No exact onset can be promised. Lack of immediate improvement does not automatically mean that another injection should be given.
There is no universal injection number or schedule. The plan depends on the diagnosis, treatment selected, health history, previous response and risks. Repeated cortisone requires individualized review. Hyaluronic acid products can have different approved administration instructions, while PRP protocols vary and are not standardized for every patient.
No. Cortisone can reduce inflammation and provide short-term symptom support for selected patients, but it does not reverse osteoarthritis, rebuild cartilage or permanently correct structural joint damage. The decision to repeat cortisone should consider previous benefit, side effects, other health conditions and alternative treatments.
No. Hyaluronic acid is considered only for selected patients with symptomatic knee osteoarthritis. It does not treat every knee condition. Professional recommendations differ, and AAOS advises against routine use. Patients should discuss the evidence, expected limitations, alternatives and possible costs before deciding whether viscosupplementation is reasonable.
PRP should not be presented as proven cartilage regeneration. AAOS reports limited evidence that PRP can reduce pain or improve function in some patients with symptomatic knee osteoarthritis, but study results and treatment methods vary. Symptom improvement does not establish that cartilage has regrown or that arthritis has been reversed.
No. Toradol IM is ketorolac administered into a muscle. It is not placed inside the knee joint and is not an image-guided joint injection. It can be considered only for short-term acute-pain support after review of gastrointestinal, kidney, cardiovascular, bleeding and medication-related risks.
Activity guidance depends on the treatment and the provider’s instructions. Some patients are advised to limit strenuous activity temporarily, while ordinary light movement can be acceptable. Follow the instructions provided for the specific procedure, and contact the clinic if pain, swelling, redness, warmth or other symptoms become severe or continue worsening.
Referral can be appropriate when there is major structural damage, persistent instability, mechanical locking, severe activity limitation or an inadequate response to appropriate nonsurgical treatment. Referral does not mean surgery is automatic. It provides an opportunity to understand surgical and nonsurgical options based on the diagnosis and the patient’s goals.
No physical Joint Health Solutions office in Gastonia has been verified. Gastonia-area patients are seen at 9350 Benfield Rd, #109, Charlotte, NC 28269. Call 704-833-3566 to discuss scheduling, treatment availability and whether a knee injection evaluation is appropriate.
If knee arthritis, swelling, stiffness or persistent pain is affecting walking and daily activity, schedule an evaluation to discuss whether an injection or another nonsurgical pathway fits your condition.
